Court of Appeals for the Sixth Circuit May 11, 2006, 04-4175 (Meridia Products Liability Litigation, Steering Committee v. Abbott Laboratories)

Also known as

United States · · · 11-05-2006

OPINION

R. GUY COLE, JR., Circuit Judge.

In this multi-district product liability case, Plaintiffs-Appellants — certain current and past consumers of the diet-drug Meridia, whose actions were transferred to, or originated in,‘.the Northern District of. Ohio — appeal the. district court’s grant of summary judgment in- favor of Defendants-Appellees, the pharmaceutical company that marketed and distributed Meri-dia and its affiliates. Plaintiffs argue on appeal that the district court (1)- failed to conduct a meaningful choice-of-law analysis, (2) erred in partly excluding the testimony of one of Plaintiffs’ experts, and (3) erred in granting summary judgment to Defendants ■ as to Plaintiffs’ various common law and statutory claims. For the reasons that follow, we AFFIRM the district .court’s grant of summary judgment.

I.

This litigation was occasioned by the diet-drug Meridia. First developed in 1980 as an anti-depressant by Boots Pharmaceuticals, Meridia works by slowing the body’s dissipation of serotonin and norepi-nephrine, brain chemicals that affect satiety and impulse control. Meridia originally failed to gain Food and Drug Administration (“FDA”) approval. In 1990, the rights to Meridia were purchased by Knoll Pharmaceuticals, which began to test the drug’s potential to effectuate weight loss. In 1997, the FDA approved the marketing and sale of Meridia as a prescription diet-drug, which Knoll began to market in 1998. In 2001, Abbott Laboratories (“Abbott Labs”) acquired Knoll. Abbott Labs now markets Meridia to doctors, pharmacies, and directly to consumers.

On March 19, 2002, a consumer watchdog group petitioned the FDA to remove Meridia from the market, alleging the drug to be ineffective and unsafe. In the wake of that petition, plaintiffs across the United States brought suit against Abbott Labs. Although peripheral to the present

*864

appeal, these plaintiffs also sued the doctors who prescribed Meridia and the pharmacies that sold it.

Read the full text

This document is published by courtlistener.com.

Moonlit adds the citation network, article-level links and cross-references, which are available to search for free.